Skip to content

The relationship between NLRP3 inflammasomes and cognitive decline in patients with Type 2 Diabetes Mellitus

The relationship between NLRP3 inflammasomes and cognitive decline in patients with Type 2 Diabetes Mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077658
Enrollment
Unknown
Registered
2023-11-15
Start date
2023-11-20
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

Normal cognitive function group :None
Mild cognitive impairment group:None

Sponsors

The Affiliated Hospita of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients whose ages above 30 years old ,met the diagnostic criteria for type 2 diabetes formulated in the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 edition), and the medical records were complete,

Exclusion criteria

Exclusion criteria: (1) patients with abnormal white blood cells count or C-reactive protein or acute infection; (2) hypoglycemic coma, diabetic ketoacidosis and and other acute complications of diabetes; (3) type I diabetes, gestational diabetes and some special type diabetes; (4) diabetes patients with other chronic complications; (5) dementia caused by acute cardiovascular and cerebrovascular diseases, personal or family mental disease history, dementia with Lewy bodies , frontotemporal dementia, vascular dementia, Parkinson's disease or multiple sclerosis; (5) suffering from malignant tumors, hematological system, autoimmune and other related diseases; (6) Depression patients (Hamilton Depression Scale total score>7 points) ;(7) have severe cognitive impairment that prevents participants from cooperating during the completion of the scale.

Design outcomes

Primary

MeasureTime frame
NOD-like receptor protein 3;Caspase-1; the MoCA score;glycosylated hemoglobin;

Secondary

MeasureTime frame
Fasting blood glucose;Fasting islet function;Postprandial Blood Glucose;Postprandial islet function indicators;triglyceride;total cholesterol;high density lipoprotein;low density lipoprotein;Renal function indicators;

Countries

China

Contacts

Public ContactChangjiang Ying

The Affiliated Hospita of Xuzhou Medical University

ycj321651@163.com+86 139 1488 8751

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026